Ann: Prana's PBT2 named one of Top Neuroscien, page-13

re: Ann: Prana's PBT2 named one of Top Ne... For phase 2 $250m is high in my books , been doing some more research on other's who have done phase 3 trials and you do have to do them on a large number of patients so the expense it quite a lot more.

Currently they are only doing 41 patients in their phase 2 trial which is not much. Others usually report positive results in phase 2 trials because of the low number of participants but when they do phase 3 with a lot more patients the results are often not that positive.

In that interview there is no mention of what their intentions are with phase 3 , do it alone or partner with one of the majors. Shall watch with interest.